Clinical Trial Update: Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating desiccated thyroid extract combined with levothyroxine for TSH suppression in intermediate-to-high risk differentiated thyroid cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Desiccated thyroid extract (desiccated thyroid extract)
• Levothyroxine (levothyroxine)

Snippet

Sponsor: West China Hospital | Conditions: Intermediate-to-High Risk Differentiated Thyroid Cancer | Phase 3 | Status: NOT_YET_RECRUITING